
[ad_1] Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US initial public offering (IPO), …
[ad_1] Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US initial public offering (IPO), …